Biomarkers in Gynecologic Tumors

Basit Öğe Kaydı
dc.contributor.authorAfsar, Selim
dc.date.accessioned2025-07-03T21:17:43Z
dc.date.issued2022
dc.departmentBalıkesir Üniversitesi
dc.description.abstractGynecologic malignancies are one of the most frequent cancers amongst women. Biomarkers are crucial for the differential diagnosis of adnexal masses; however, their potential for diagnosis is limited. In the era of difficulty in ovarian cancer screening, novel biomarkers are defined, but CA125 still remains the most valuable one. Circulating tumor DNAs, DNA hypermethylation, metabolites, microRNAs, and kallikreins have recently turned out as ovarian cancer biomarkers and are being applied to clinical practice. For uterine cancer, genomic classification has now been described, it will be used as a prognostic tool. In this chapter, we describe ovarian, endometrial, and cervical cancer biomarkers in detail. © 2022, Bentham Books imprint.
dc.identifier.doi10.2174/9789815040463122010004
dc.identifier.endpage36
dc.identifier.isbn978-981504046-3
dc.identifier.isbn978-981504047-0
dc.identifier.scopus2-s2.0-85210686647
dc.identifier.scopusqualityQ2
dc.identifier.startpage16
dc.identifier.urihttps://doi.org/10.2174/9789815040463122010004
dc.identifier.urihttps://hdl.handle.net/20.500.12462/21014
dc.indekslendigikaynakScopus
dc.institutionauthorAfsar, Selim
dc.language.isoen
dc.publisherBentham Science Publishers
dc.relation.ispartofBiomarkers in Medicine
dc.relation.publicationcategoryKitap Bölümü - Uluslararası
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_Scopus_20250703
dc.subjectBiomarker
dc.subjectCA125
dc.subjectCervical cancer
dc.subjectCfDNA
dc.subjectHE4
dc.subjectHigh-copy number
dc.subjectMiRNA
dc.subjectMSI
dc.subjectMSS
dc.subjectOvarian cancer
dc.subjectPOLE-mutated
dc.subjectROMA
dc.subjectSCC-Ag
dc.subjectUterine cancer
dc.titleBiomarkers in Gynecologic Tumors
dc.typeBook Chapter

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu